HEADER HYDROLASE/ANTIBIOTIC 06-MAY-14 4QB8 TITLE CRYSTAL STRUCTURE OF BETA-LACTAMASE FROM M.TUBERCULOSIS FORMING TITLE 2 MICHAELIS MENTEN WITH TEBIPENEM COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 42-307; COMPND 5 SYNONYM: PENICILLINASE; COMPND 6 EC: 3.5.2.6; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 STRAIN: ATCC 25618 / H37RV; SOURCE 5 GENE: BLAA, BLAC, RV2068C, MTCY49.07C; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS 3-LAYER SANDWICH, DD-PEPTIDASE/BETA-LACTAMASE SUPERFAMILY, TEBIPENEM KEYWDS 2 PIVOXIL, CARBAPENEM, DESTROYING BETALACTAM ANTIBIOTICS, HYDROLASE- KEYWDS 3 ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.HAZRA,J.BLANCHARD REVDAT 2 27-AUG-14 4QB8 1 JRNL REVDAT 1 20-AUG-14 4QB8 0 JRNL AUTH S.HAZRA,H.XU,J.S.BLANCHARD JRNL TITL TEBIPENEM, A NEW CARBAPENEM ANTIBIOTIC, IS A SLOW SUBSTRATE JRNL TITL 2 THAT INHIBITS THE BETA-LACTAMASE FROM MYCOBACTERIUM JRNL TITL 3 TUBERCULOSIS. JRNL REF BIOCHEMISTRY V. 53 3671 2014 JRNL REFN ISSN 0006-2960 JRNL PMID 24846409 JRNL DOI 10.1021/BI500339J REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.1_1168) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 25431 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.154 REMARK 3 R VALUE (WORKING SET) : 0.153 REMARK 3 FREE R VALUE : 0.178 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1279 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 23.4771 - 3.6522 0.99 2865 151 0.1539 0.1455 REMARK 3 2 3.6522 - 2.9006 1.00 2741 144 0.1424 0.1720 REMARK 3 3 2.9006 - 2.5344 1.00 2736 144 0.1568 0.1740 REMARK 3 4 2.5344 - 2.3029 0.99 2687 142 0.1473 0.1942 REMARK 3 5 2.3029 - 2.1380 0.99 2652 142 0.1448 0.2158 REMARK 3 6 2.1380 - 2.0120 0.99 2668 143 0.1394 0.1657 REMARK 3 7 2.0120 - 1.9113 0.98 2596 135 0.1582 0.1680 REMARK 3 8 1.9113 - 1.8281 0.97 2624 138 0.1575 0.2083 REMARK 3 9 1.8281 - 1.7577 0.97 2583 140 0.2204 0.2507 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.160 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2084 REMARK 3 ANGLE : 1.363 2855 REMARK 3 CHIRALITY : 0.073 327 REMARK 3 PLANARITY : 0.006 375 REMARK 3 DIHEDRAL : 14.087 786 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QB8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAY-14. REMARK 100 THE RCSB ID CODE IS RCSB085835. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25431 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 23.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, PH 7.5, 2M NH4H2PO4 REMARK 280 PROTEIN CONCENTRATION 12 MGS/ML, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.78450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.55250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.77900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.55250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.78450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.77900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 706 O HOH A 777 2.13 REMARK 500 OD1 ASP A 280 O HOH A 777 2.14 REMARK 500 O HOH A 809 O HOH A 810 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 679 O HOH A 685 2455 2.05 REMARK 500 O HOH A 653 O HOH A 719 4555 2.12 REMARK 500 O HOH A 649 O HOH A 709 2454 2.14 REMARK 500 O HOH A 585 O HOH A 672 3444 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 42 33.25 -157.49 REMARK 500 THR A 66 -167.37 -122.12 REMARK 500 CYS A 83 -148.25 49.30 REMARK 500 GLU A 181 -166.50 -105.11 REMARK 500 ARG A 236 -118.79 -113.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1TE A 405 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4Q8I RELATED DB: PDB DBREF 4QB8 A 42 307 UNP P9WKD3 BLAC_MYCTU 42 307 SEQADV 4QB8 ALA A 41 UNP P9WKD3 EXPRESSION TAG SEQADV 4QB8 ALA A 87 UNP P9WKD3 LYS 87 ENGINEERED MUTATION SEQRES 1 A 267 ALA ALA ASP LEU ALA ASP ARG PHE ALA GLU LEU GLU ARG SEQRES 2 A 267 ARG TYR ASP ALA ARG LEU GLY VAL TYR VAL PRO ALA THR SEQRES 3 A 267 GLY THR THR ALA ALA ILE GLU TYR ARG ALA ASP GLU ARG SEQRES 4 A 267 PHE ALA PHE CYS SER THR PHE ALA ALA PRO LEU VAL ALA SEQRES 5 A 267 ALA VAL LEU HIS GLN ASN PRO LEU THR HIS LEU ASP LYS SEQRES 6 A 267 LEU ILE THR TYR THR SER ASP ASP ILE ARG SER ILE SER SEQRES 7 A 267 PRO VAL ALA GLN GLN HIS VAL GLN THR GLY MET THR ILE SEQRES 8 A 267 GLY GLN LEU CYS ASP ALA ALA ILE ARG TYR SER ASP GLY SEQRES 9 A 267 THR ALA ALA ASN LEU LEU LEU ALA ASP LEU GLY GLY PRO SEQRES 10 A 267 GLY GLY GLY THR ALA ALA PHE THR GLY TYR LEU ARG SER SEQRES 11 A 267 LEU GLY ASP THR VAL SER ARG LEU ASP ALA GLU GLU PRO SEQRES 12 A 267 GLU LEU ASN ARG ASP PRO PRO GLY ASP GLU ARG ASP THR SEQRES 13 A 267 THR THR PRO HIS ALA ILE ALA LEU VAL LEU GLN GLN LEU SEQRES 14 A 267 VAL LEU GLY ASN ALA LEU PRO PRO ASP LYS ARG ALA LEU SEQRES 15 A 267 LEU THR ASP TRP MET ALA ARG ASN THR THR GLY ALA LYS SEQRES 16 A 267 ARG ILE ARG ALA GLY PHE PRO ALA ASP TRP LYS VAL ILE SEQRES 17 A 267 ASP LYS THR GLY THR GLY ASP TYR GLY ARG ALA ASN ASP SEQRES 18 A 267 ILE ALA VAL VAL TRP SER PRO THR GLY VAL PRO TYR VAL SEQRES 19 A 267 VAL ALA VAL MET SER ASP ARG ALA GLY GLY GLY TYR ASP SEQRES 20 A 267 ALA GLU PRO ARG GLU ALA LEU LEU ALA GLU ALA ALA THR SEQRES 21 A 267 CYS VAL ALA GLY VAL LEU ALA HET PO4 A 401 5 HET PO4 A 402 5 HET PO4 A 403 5 HET PO4 A 404 5 HET 1TE A 405 25 HETNAM PO4 PHOSPHATE ION HETNAM 1TE TEBIPENEM HETSYN 1TE (2S,3R,4R,5S,6S)-6-[(1R)-1-HYDROXYETHYL]-4-METHYL-7- HETSYN 2 1TE OXO-3-{[1-(1,3-THIAZOL-2-YL)AZETIDIN-3-YL]SULFANYL}-1- HETSYN 3 1TE AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID FORMUL 2 PO4 4(O4 P 3-) FORMUL 6 1TE C16 H21 N3 O4 S2 FORMUL 7 HOH *312(H2 O) HELIX 1 1 ASP A 43 ASP A 56 1 14 HELIX 2 2 CYS A 83 THR A 85 5 3 HELIX 3 3 PHE A 86 ASN A 98 1 13 HELIX 4 4 PRO A 99 ASP A 104 5 6 HELIX 5 5 THR A 110 ILE A 114 5 5 HELIX 6 6 VAL A 120 VAL A 125 1 6 HELIX 7 7 ILE A 131 TYR A 141 1 11 HELIX 8 8 ASP A 143 GLY A 155 1 13 HELIX 9 9 PRO A 157 GLY A 159 5 3 HELIX 10 10 GLY A 160 LEU A 171 1 12 HELIX 11 11 PRO A 183 ARG A 187 5 5 HELIX 12 12 THR A 198 LEU A 211 1 14 HELIX 13 13 PRO A 216 ARG A 229 1 14 HELIX 14 14 ARG A 236 PHE A 241 1 6 HELIX 15 15 ARG A 281 GLY A 285 5 5 HELIX 16 16 ARG A 291 ALA A 307 1 17 SHEET 1 A 5 ILE A 72 TYR A 74 0 SHEET 2 A 5 ARG A 58 VAL A 63 -1 N VAL A 61 O TYR A 74 SHEET 3 A 5 PRO A 272 ASP A 280 -1 O MET A 278 N GLY A 60 SHEET 4 A 5 ARG A 258 TRP A 266 -1 N VAL A 265 O TYR A 273 SHEET 5 A 5 LYS A 246 GLY A 254 -1 N GLY A 252 O ASN A 260 SHEET 1 B 2 PHE A 80 ALA A 81 0 SHEET 2 B 2 THR A 196 THR A 197 -1 O THR A 197 N PHE A 80 SHEET 1 C 2 LEU A 106 ILE A 107 0 SHEET 2 C 2 MET A 129 THR A 130 -1 O MET A 129 N ILE A 107 CISPEP 1 ALA A 42 ASP A 43 0 -0.31 CISPEP 2 GLU A 182 PRO A 183 0 3.56 SITE 1 AC1 9 ARG A 79 ARG A 187 GLU A 193 ASP A 255 SITE 2 AC1 9 TYR A 286 HOH A 643 HOH A 702 HOH A 703 SITE 3 AC1 9 HOH A 798 SITE 1 AC2 8 ARG A 53 GLN A 133 HOH A 517 HOH A 554 SITE 2 AC2 8 HOH A 591 HOH A 717 HOH A 751 HOH A 812 SITE 1 AC3 5 ARG A 140 TYR A 141 HOH A 509 HOH A 517 SITE 2 AC3 5 HOH A 554 SITE 1 AC4 4 ARG A 75 GLU A 78 ARG A 115 GLU A 184 SITE 1 AC5 13 SER A 84 ILE A 117 SER A 142 GLU A 182 SITE 2 AC5 13 THR A 251 GLY A 252 THR A 253 HOH A 693 SITE 3 AC5 13 HOH A 699 HOH A 700 HOH A 701 HOH A 711 SITE 4 AC5 13 HOH A 796 CRYST1 49.569 67.558 75.105 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020174 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014802 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013315 0.00000 MASTER 279 0 5 16 9 0 12 6 0 0 0 21 END